Posted by AGORACOM-JC
at 3:07 PM on Tuesday, April 20th, 2021
Electronic decoy product advances to sponsorship and evaluation with U.S. military and another NATO nation
Announced the award of U.S. patent 10,969,467 B1 for Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy
This patent is one of the core technologies of the Company’s PhantomTM electronic decoy, as described in the press releases of October 5th and December 30th, 2020
Ottawa, Ontario–(April 20, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced the award of U.S. patent 10,969,467 B1 for Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy. This patent is one of the core technologies of the Company’s PhantomTM electronic decoy, as described in the press releases of October 5th and December 30th, 2020.
In conjunction with the patent award, the Company confirmed that the PhantomTM system has just been selected in defence and innovation programs for evaluation, including a U.S. Special Operations Command program, and has been prequalified for government funding with an estimated initial value of approximately $1 million once approved.
“Apart from the potential near-term dollars involved, this qualification and invitation to participate in trials with key agencies in the U.S. and another NATO country signals serious interest in the PhantomTM system,” said Jeff MacLeod, KWESST Founder, President and CEO. He adds that, “These concurrent developments also appear likely to accelerate the pace of market uptake. Accordingly, with the upcoming close of our $4 million financing announced April 9, 2021 we will be prioritizing the productization of PhantomTM to be in the market sooner than originally planned.”
The Company stated that there is growing interest among NATO and partner countries for a tactical electronic decoy to prevent adversaries from locating and targeting friendly forces. This growing interest stems from incidents like one publicly reported in the 2016 where two full Ukrainian mechanized battalions were annihilated by Russian adversaries in three minutes with precision mass fire after locating them based on their electronic signal emissions.
About the PhantomTM electronic decoy PhantomTM is a compact, lightweight electromagnetic transmitter capable of mimicking the electromagnetic signature of a tactical military unit, fooling adversaries as to the location of NATO and partner nation forces. Recent interest from NATO agencies and defence contractors for this product has resulted in KWESST moving up the scheduled production of demonstration samples of PhantomTM in the Company’s priorities. An earlier prototype version of PhantomTM was procured and successfully trialed in military exercises. The latest version is more compact, with greater capability, and is soldier-portable or can be deployed by Unmanned Aerial Systems (“UAVs” or “drones”). Based on internal research the Company estimates the market for a system like PhantomTM to be worth several hundred million dollars in the U.S. alone.
Posted by AGORACOM-JC
at 9:58 AM on Monday, April 19th, 2021
Total revenue for the year ended December 31, 2020, increased by 216.1% to $4.36 million, compared to $1.38 million in 2019
Vancouver, BC., April 19, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“ Draganfly ” or the “ Company ”), an award-winning, industry-leading manufacturer and systems developer, is pleased to announce its fourth quarter and fiscal 2020 financial results. Revenue growth for the fourth quarter and the year was driven by a combination of organic growth, the acquisition of Dronelogics Systems Inc. (“ Dronelogics ”), and sales from COVID-19 screening products.
The financial year 2020 was another milestone year for Draganfly. The Company successfully closed and integrated its Dronelogics acquisition which, as planned, became the driver of the bulk of Draganfly new product revenue sales. The Company’s main custom engineering customer effectively shut down this portion of its business in Q1 2020 primarily due to COVID-19; however, services revenues were successfully offset by other drone services work. 2020 revenues were up 216% year over year coming in at $4,363,511 versus $1,380,427 in the previous year. $645,756 represents custom engineering services work, $630,532 represents drone services work and the balance of revenue was from its hardware sales.
The Company recently added health monitoring and prevention to its product and service offering. Securing some key clients in this business line was key to proving out this new vertical. These clients were important for validation of this new technology, but more importantly, it demonstrated the Company’s ability to evolve and offer products and services that have global applicability.
Financial Highlights – 2020:
● Total revenue for the year ended December 31, 2020, increased by 216.1% to $4.36 million, compared to $1.38 million in 2019.
● As a result of increased product sales and service revenue, the Company’s gross profit increased by $597,973, or 51.5%. As a percentage of sales, gross margin ( 1) decreased from 84.1% in 2019 to 40.3% in 2020. This shift in gross margin is due to a higher percentage of hardware sales.
● The Company recorded a comprehensive loss of $8,015,709 compared to a comprehensive loss of $11,095,057 in 2019. The decreased loss was largely the result of the lack of listing expense resulting from the 2019 amalgamation and the funds received from the disposition of an investment that had been previously written off.
● The Company’s cash balance on December 31, 2020, was $1.98 million compared to $2.43 million on December 31, 2019.
For the year ended December 31,
2020
2019
Total revenues
$
4,363,511
$
1,380,427
Gross Profit (as a % of revenues)
40.3
%
84.1
%
Net loss
(8,015,813
)
(11,095,057
)
Net loss per share ($)
– Basic
(0.10
)
(0.23
)
– Diluted
(0.10
)
(0.23
)
Comprehensive loss
(8,015,709
)
(11,095,057
)
Comprehensive loss per share ($)
– Basic
(0.10
)
(0.23
)
– Diluted
(0.10
)
(0.23
)
Change in cash and cash equivalents
(447,063
)
2,349,954
Total assets
7,100,567
3,221,783
Working capital
1,214,371
2,037,906
Total non-current liabilities
104,885
93,073
Shareholder’s equity (deficiency)
$
3,848,205
$
2,191,353
Number of shares outstanding
86,093,361
69,670,613
Financial Highlights – Fourth Quarter 2020:
● Revenue for Q4 2020, increased by 202.3% to $1.49 million, compared to $492 thousand for Q4 2019. The substantial increase in revenue is largely due to the Company’s acquisition of Dronelogics and the retail sales and services business that the acquisition brought partially offset by a decrease in custom engineering services due to the downturn caused by COVID-19.
● Gross margin percentage for Q4 2020 was 22.2% compared to 91.4% in Q4 2019. The decrease is due to the sales mix as product sales tend to have a much lower margin than those of custom engineering services.
●Total comprehensive loss for the Q4 2020, was $3.74 million compared to $2.03 million for the same period in 2019. The increase was due to higher office and miscellaneous expenses.
2020 Q4
2020 Q3
2019 Q4
Revenue
$
1,486,009
$
1,453,905
$
491,520
Cost of goods sold
$
(1,155,491
)
$
(893,441
)
$
(42,401
)
Gross profit
$
330,518
$
560,464
$
449,119
Gross margin – percentage
22.2
%
38.5
%
91.4
%
Operating expenses
$
(3,359,508
)
$
(2,852,003
)
$
(2,983,115
)
Operating loss
$
(3,028,990
)
$
(2,291,539
)
$
(2,533,996
)
Operating loss per share – basic
$
(0.04
)
$
(0.03
)
$
(0.04
)
Operating loss per share – diluted
$
(0.04
)
$
(0.03
)
$
(0.04
)
Other income (expense)
$
(713,885
)
$
91,228
$
506,080
Comprehensive loss
$
(3,741,640
)
$
(2,201,543
)
$
(2,027,916
)
Comprehensive loss per share – basic
$
(0.05
)
$
(0.03
)
$
(0.03
)
Comprehensive loss per share – diluted
$
(0.05
)
$
(0.03
)
$
(0.03
)
Cameron Chell, CEO of Draganfly, said: “We have seen tremendous growth in the first quarter of 2021 around some key initiatives including education, military, security, mining, telehealth, and our 24hr pathogen sequestration and kill sanitizing spray applied via patented drone technology. The Draganfly team is looking forward to continuing to build on those relationships, technologies, and innovations.”
Q4 2020 and Q1 2021 milestones include the following:
● Secured $1 MM flight services contract to deploy EagleEye ™ AI flight services with Windfall Geotek Inc. Windfall Geotek flies mining prospect with magnetometers with data placed into EagleEye ™ and provides recommended targets for mining companies to drill.
● Raised US$16,450,000 million through the issuance of securities under the Company’s Regulation A offering filed with the U.S. Securities and Exchange Commission.
● Entered into an agreement with Southern Alberta Institute of Technology to advance UAV delivery technology, which will include (i) designing, developing, and testing of a cargo system for medical delivery to be mounted on a variety of drones including VTOL rotary and fixed-wing platforms, (ii) developing test protocols, operational procedures, and standards for Beyond Visual Line of Sight medical delivery operation within the framework of Transport Canada, US Federal Aviation Agency, and European Union Aviation Safety Agency procedures and protocols and (iii) developing an operational manual for BVLOS operation of heavy lifting and long endurance RPASS to be used for commercial application under an Air Operator’s Certificate.
● Partnership with Steve Wozniak’s K-12 program Woz ED to be the exclusive supplier of drones to Woz ED’s drone program across its national K-12 curriculum and received orders for the sale of 2,000 drones. To clarify the Company’s news release dated March 2, 2021, the Company entered into a memorandum of understanding with Woz ED with the objective to create the terms and conditions surrounding a business agreement. The memorandum of understanding automatically terminates after 60 days; however, the Company anticipates entering into a definitive agreement with Woz ED during Q2 2021.
● Talladega College implemented Vital Intelligence Smart Vital assessment platform, Vital Signs Assessment Stations, and Social Distancing awareness technologies to be used campus-wide to detect potential symptoms of COVID-19.
● Portage County Sheriff’s Department deployed Vital Intelligence Technology to be used to pre-screen inmates and detainees before bringing them into detention.
● Barrett-Jackson Auction Company implementing Draganfly’s Safely Opening Sites protocol for its March 2021 collector car auction in Scottsdale, AZ. including patented drone technology of the Varigard one-of-a-kind, revolutionary organic sanitizer that provides up to 24-hour of pathogen sequestration and kill-efficacy.
● Design and deliver Vital Intelligence technology into The 517 Group’s Hospitality and Entertainment Service Organization.
● Selected by Coldchain Technology Services, LLC (“ Coldchain ”) to develop and provide flight services for drone delivery of the COVID-19 vaccine. To clarify the Company’s news release dated December 22, 2020, the Company entered into a letter of intent with Coldchain with the objective to create the terms and conditions surrounding a business agreement for the development of a vaccine delivery payload system and associated flight services. The letter of intent automatically terminates after 90 days; however, the Company anticipates entering into a definitive agreement with Coldchain during Q2 2021.
● Providing engineering and development services for drone-based air support defense system for Integrated Launcher Solutions (“ ILS ”). To clarify the Company’s news release dated January 21, 2021, the Company entered into a memorandum of understanding with ILS with the objective to create the terms and conditions surrounding a project management and development agreement for the production of ILS’s multi-launching air support defense system. The memorandum of understanding automatically terminates after 60 days; however, the Company anticipates entering into a definitive agreement with ILS during Q2 2021.
● Draganfly selected by Knightscope to integrate mobile Vital Sign Screening technology into its autonomous security robots.
● Issued new delivery drone patent for variable center of gravity vertical take-off and landing aircraft. US Patent No. 10,807,707 is an unmanned aircraft system (UAS) configured for both vertical take-off and landing (VTOL) and fixed-wing flight operations includes forward, and aft wing assemblies mounted to the fuselage, each wing assembly including port and starboard nacelles terminating in motor-driven rotors powered by an onboard control system capable of adjusting rotor speeds.
● Closed an acquisition of assets from Vital Intelligence Inc. on March 25, 2021, in consideration for (a) a cash payment of $500,000 with $250,000 paid at closing and $250,000 to be paid on the six-month anniversary date of closing; and (b) 6,000,000 units of the Company with each unit being comprised of one common share of the Company and one common share purchase warrant. The units are subject to escrow with 1,500,000 units released at closing and the remainder to be released upon the Company reaching certain revenue milestones received from the purchased assets. Each warrant entitles the holder to acquire one common share for a period of 24 months at an exercise price of $2.67 per common share and the Company can accelerate the expiry date of the warrants after one year in the event the underlying common shares have a value of at least 30% greater than the exercise price of the warrants.
All financial information in this press release is prepared in accordance with International Financial Reporting Standards as issued by the International Accounting Standards Board. The Company will file its consolidated financial statements for the year ended December 31, 2020, and associated management discussion and analysis under the Company’s profile on SEDAR at www.sedar.com .
Note 1: this press release refers to “gross margin” which does not have any standardized meaning prescribed by generally accepted accounting principles in Canada (” GAAP “). Gross margin is defined as gross profit divided by revenue and is often presented as a percent. Draganfly’s management believes that gross margin and other non-GAAP measures provide useful information to investors as it provides them with supplemental measures of the Company’s operating performance and liquidity and thus highlights trends in the Company’s business that may not otherwise be apparent when relying solely on GAAP measures. Management also uses non-GAAP measures and metrics in order to facilitate operating performance comparisons from period to period, to prepare annual operating budgets and forecasts and to determine components of executive compensation. For more information with respect to financial measures which have not been defined by GAAP, including reconciliations to the closest comparable GAAP measure, see the “Non-GAAP Measures and Additional GAAP Measures” section of the Company’s most recent MD&A which is available on SEDAR.
AboutDraganfly
Draganfly Inc. (CSE: DFLY; OTCQB: DFLYF; FSE: 3U8) is the creator of quality, cutting-edge software, and systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 22 years, Draganfly is an award-winning, industry-leading manufacturer and technology developer serving the public safety, agriculture, industrial inspections, security, and mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.
Company Contact Cameron Chell, CEO PH: 310-658-4413 Email: [email protected]
Forward-Looking Statements
This release contains certain “forward looking statements” and certain “forward-looking information” as defined under applicable Canadian securities laws. Forward-looking statements and information can generally be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”, “plans” or similar terminology. Forward-looking statements and information are based on forecasts of future results, estimates of amounts not yet determinable and assumptions that, while believed by management to be reasonable, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Forward-looking statements and information are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of the Company to control or predict, that may cause the Company’s actual results, performance or achievements to be materially different from those expressed or implied thereby, and are developed based on assumptions about such risks, uncertainties and other factors set out here in, including but not limited to: the potential impact of epidemics, pandemics or other public health crises, including the current outbreak of the novel coronavirus known as COVID-19 on the Company’s business, operations and financial condition, the successful integration of technology, the inherent risks involved in the general securities markets; uncertainties relating to the availability and costs of financing needed in the future; the inherent uncertainty of cost estimates and the potential for unexpected costs and expenses, currency fluctuations; regulatory restrictions, liability, competition, loss of key employees and other related risks and uncertainties disclosed under the heading “Risk Factors“ in the Company’s most recent filings filed with securities regulators in Canada on the SEDAR website at www.sedar.com. The Company undertakes no obligation to update forward-looking information except as required by applicable law. Such forward-looking information represents managements’ best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information.
Posted by AGORACOM-JC
at 8:30 AM on Friday, April 16th, 2021
Announce the receipt of TSXV approval and completion, on April 14, 2021, of the acquisition of mediahelden GmbH d/b/a/ Passcreator by Loop.
Due to rounding, the number of common shares of Loop issued as consideration was revised to 1,301,425, all other consideration paid as set out in the prior news release remains the same.
VANCOUVER, British Columbia, April 16, 2021 — Further to the Company’s press release dated March 29, 2021, Loop Insights Inc. (TSXV: MTRX; OTCQB: RACMF) (the “ Company ” or “ Loop ”), a provider of contactless solutions and artificial intelligence (“ AI ”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the receipt of TSXV approval and completion, on April 14, 2021, of the acquisition of mediahelden GmbH d/b/a/ Passcreator by Loop. Due to rounding, the number of common shares of Loop issued as consideration was revised to 1,301,425, all other consideration paid as set out in the prior news release remains the same.
About Passcreator
Passcreator is a German wallet pass software company that offers clients a software as a service solution for mobile marketing. Compatible with wallet apps on both iOS and Android, Passcreator seamlessly integrates with existing marketing platforms, as well as supports the creation of new ones. Furthermore, Passcreator is fully GDPR compliant and highly scalable. This solution is suitable for companies of all sizes.
About Loop
Loop is a Vancouver-based Internet of Things (” IoT “) technology company that delivers transformative artificial intelligence (” AI “) automated marketing, contact tracing, and contactless solutions to the brick and mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real- time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network and sold through the TELUS IoT Marketplace.
Posted by AGORACOM-JC
at 6:20 PM on Thursday, April 15th, 2021
Announces that at March 31, 2021, its unaudited net asset value per share (“NAV”) was $1.25.
TORONTO, April 15, 2021 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at March 31, 2021, its unaudited net asset value per share (“NAV”) was $1.25.
This announcement is made based on ThreeD’s newly established practice of releasing NAV on a monthly basis as part of the Company’s ongoing response to shareholder interest in receiving periodic information. NAV is calculated based on unaudited month-end financial information.
Use of Non-GAAP Financial Measures:
This press release contains references to NAV or “net asset value per share” which is a non-GAAP financial measure. NAV is calculated as the value of total assets less the value of total liabilities divided by the total number of common shares outstanding as at a specific date. The term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies. There is no comparable GAAP financial measure presented in ThreeD’s consolidated financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measure. The Company believes that the measure provides information useful to its shareholders in understanding the Company’s performance, and may assist in the evaluation of the Company’s business relative to that of its peers. This data is furnished to provide additional information and does not have any standardized meaning prescribed by GAAP. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP, and is not necessarily indicative of other metrics presented in accordance with GAAP. Existing NAV of the Company is not necessarily predictive of the Company’s future performance or the NAV of the Company as at any future date.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.
For further information: Lynn Chapman, CPA, CA Chief Financial Officer and Corporate Secretary [email protected] Phone: 416-941-8900
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future disclosure of NAV by the Company and the approximate timing thereof. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur including, without limitation, risks relating to the timing and content of future public disclosures by the Company or related to the fact that the term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies and may not be indicative of NAV for any future periods. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Posted by AGORACOM-JC
at 8:16 AM on Thursday, April 15th, 2021
Company Stock Is Now More Accessible to U.S. Investors
United States investors may now more easily trade Empower’s OTC stock (OTC PINK:EPWCF) in addition to Empower’s listing on the CSE (CSE:CBDT) and (FRA:8EC).
VANCOUVER B.C. / April 15, 2021 /EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTC PINK:EPWCF) (“Empower” or the “Company”) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens – is pleased to announce it is now eligible for Depository Trust Company (“DTC”) services in relation to Empower’s listing on the OTC.
United States investors may now more easily trade Empower’s OTC stock (OTC PINK:EPWCF) in addition to Empower’s listing on the CSE (CSE:CBDT) and (FRA:8EC).
“Convenience is a core part of Empower’s overall strategy for our approach to integrated healthcare, so our capital markets strategy should be the same. I’m thrilled that trading Empower’s shares will now be easier for existing and potential shareholders in the U.S.,” said Steven McAuley, Chairman & CEO of Empower. “Empower has a strong and growing presence in the United States market operationally as well as for investors. We’re confident that we will see enhanced trading liquidity as a result of our DTC eligibility.”
DTC is a subsidiary of the Depository Trust and Clearing Corporation (DTCC), one of the world’s largest securities depositories that manages the electronic clearing and settlement of publicly traded companies. Empower is now eligible to be electronically cleared and settled through the DTC and is therefore considered “DTC eligible”. This electronic method of clearing securities streamlines the process of trading, enhances liquidity, and provides direct access to investors and brokers in the U.S. OTC capital markets.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Posted by AGORACOM-JC
at 9:28 AM on Wednesday, April 14th, 2021
Announced that it has appointed Rick Bowes, CD, MA, MBA in the new position of Vice President, Operations to oversee and accelerate market introduction of the Company’s products and services for Digitization and Tactical Products (“DTP”).
The DTP business unit comprises the bulk of the Company’s current products and services, including TASCS, ATAK integration, the GreyGhostTM micro missile against hostile drones, the laser defence system and the Phantom electronic decoy.
Appointments are part of KWESST’s expanded business plan
Ottawa, Ontario–(April 14, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced that it has appointed Rick Bowes, CD, MA, MBA in the new position of Vice President, Operations to oversee and accelerate market introduction of the Company’s products and services for Digitization and Tactical Products (“DTP”). The DTP business unit comprises the bulk of the Company’s current products and services, including TASCS, ATAK integration, the GreyGhostTM micro missile against hostile drones, the laser defence system and the Phantom electronic decoy.
In conjunction, the Company also announced that Steve Archambault, who has been serving as part-time Chief Financial Officer since the Company’s listing in September 2020, will now assume this role on a full-time basis.
“With the expected closing of our recently announced $4 million over-subscribed brokered private placement, KWESST is positioned to execute on an expanded business plan,” said Jeff MacLeod, KWESST Founder, President and CEO. “The appointments announced today add bench strength for accelerated market introduction across our growing portfolio of products and services.”
“We are very pleased indeed to welcome Rick as VP Operations,” added David Luxton, Executive Chairman. “He brings a rare combination of senior defence industry experience and domain knowledge that is directly relevant to our key markets and programs. He also has proven business capture experience and long-standing relationships with major defence contractors. We are equally pleased that Steve Archambault has committed to the Company on a dedicated, full-time basis in the role of CFO.”
About Rick Bowes
Prior to his various senior roles with defence contractors such as General Dynamics Canada, DRS Technologies Canada (now Leonardo DRS), ATCO Frontec and ADGA Group Inc., Rick had a distinguished career as a senior officer in the Canadian Army, retiring in 2003 as a Lieutenant Colonel. He is a graduate of Royal Military College of Canada and served in various operational and staff roles in the Canadian military and on secondment to the British Army. As an armour officer, Rick served with various units such as Lord Strathcona’s Horse (Royal Canadians) and the Canadian Airborne Regiment Battle Group across Canada and in deployed operations in Bosnia-Herzegovina with the UN Protection Force and the NATO Stabilization Force (SFOR). Rick was also part of the planning team for Canada’s participation in the NATO Kosovo Force (KFOR) mission in 1999.
The Company stated that the terms of these appointments include a grant of 300,000 stock options to Rick Bowes, with each stock option being exercisable at a price equal to the closing price of the Company’s shares on the TSX Venture Exchange on April 16th, 2021 on or before April 13, 2026 and a grant of Restricted Share Units (“RSU”s) to Steve Archambault equal to $25,000 divided by the closing price of the Company’s shares on the TSX Venture Exchange on April 16th, 2021.
Posted by AGORACOM-JC
at 8:50 AM on Wednesday, April 14th, 2021
Announced that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021
VANCOUVER, BC , April 14, 2021 – ELSE NUTRITION HOLDINGS INC.(TSXV: BABY.V) (OTCQX: BABYF) (FSE: 0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , announces that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021.
“Launching at Natural Grocers by Vitamin Cottage drives significant and strategic distribution for the brand. We are particularly excited by the alignment between this retailer and with our brand, both focusing on helping people through sustainable, organic nutrition solutions, said Hamutal Yitzhak , Else CEO and Co-Founder. “We are eager to bring real, organic and whole food-based, clean label solutions to families in this region,” she added.
About Natural Grocers by Vitamin Cottage
Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is one of the leading natural food grocers in the US, with 159 stores in 20 states west of the Mississippi river. Founded in 1955, Natural Grocers is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers’ flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, safe, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers make informed health and nutrition choices.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Posted by AGORACOM-JC
at 8:36 AM on Wednesday, April 14th, 2021
Announced that Kai Medical Laboratory has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.
VANCOUVER, BC / April 14, 2021 / EMPOWER CLINICS INC. (CSE:CBDT) (Frankfurt:8EC) (OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that Kai Medical Laboratory (“KAI”) has received an order for COVID-19 RT-PCR tests that is anticipated to be in excess of $CAD 750,000 from two new film and television productions.
5,000 TEST ORDER FOR FILM & TELEVISION PRODUCTIONS REPRESENTS REPEAT ORDER BASED ON CONSISTENT PERFORMANCE OF KAI MEDICAL LAB
In early October, shortly after the acquisition of KAI, Empower announced an agreement to process approximately 1,000 COVID-19 RT-PCR tests for a major film & TV production over a 30-day period, with the possibility of more business upon successful completion of the initial tests.
On November 16, 2020 KAI received a repeat and record COVID-19 testing order for approximately 9,000 units in excess of $CAD 1,000,000 over a four-month period.
Today’s announcement represents a repeat Purchase Order of approximately 5,000 units to be processed over just a two-month period. The total revenue from this order is anticipated to be in excess of $CAN 750,000.
“Our team at KAI continues to deliver the type of performance to Tier-1 clients that is worthy of significant repeat business that serves as unequivocal validation of our capabilities,” said Steven McAuley, Chairman & CEO of Empower. “To this end, the magnitude of KAI’s growth and success cannot be overstated as it continues to focus on very active business development and product development, setting a path toward significant North American growth in the midst of tripling its size. KAI is well on its way to becoming a national brand supported by our strong working capital position and a team dedicated to performance.”
As of September 1st, KAI has already processed tests for multiple different film and television productions in key US markets including Los Angeles, Atlanta, New York, Dallas, earning the highest confidence of the industry.
KAI MEDICAL LABORATORY NOW EXPANDING TO TRIPLE CURRENT SIZE IN ANTICIPATION OF ANTICIPATED RAPID TEST GROWTH
KAI continues to progress on the design and build out of the laboratory expansion to prepare to meet upcoming demand in a number of areas. First, the continued processing of RT-PCR tests for film & television productions, commercial accounts and enterprise level clients. Second, the full e-commerce impact of KaiTests.com and the national direct-to-consumer marketing programs for KAI Saliva, an FDA, EUA authorized and Health Canada approved at-home Saliva COVID-19 RT-PCR Test. KAI Saliva provides travellers, both foreign and domestic with a simple, fully compliant method to obtain an RT-PCR test and test result prior to arriving or coming back into Canada and USA, or arriving in other countries that have similar executive travel orders.
Finally, KAI Labs continues the development of new direct-to-consumer test protocols that will expand the product offers on Kaitests.com throughout 2021 and beyond.
McAuley added “With each passing month Empower gains more strength and velocity in every aspect of our business from KAI Lab in Dallas to our rapidly expanding clinic operations in Canada and our direct-to-consumer products such as KAI Saliva. All of which are amply funded well into the future with our strongest balance sheet ever thanks to the receipt of more than $12,000,000 in warrant conversions as of last month. We are on a path, a trajectory towards building a great health and wellness company across North America, and I look forward to providing our shareholders with further specifics.”
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, small cap Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca $EPWCF Kai Medical Lab Receives Order for Up To 5,000 Covid-19 Tests from Two Film & Television Productions in Excess Of $750,000 $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca
Posted by AGORACOM-JC
at 8:33 AM on Tuesday, April 13th, 2021
Announce a three year revenue white label mobile app partnership agreement with Automotive Industries (AI) trade publication
Automotive Industries print audience plus Ai’s online readership are the who’s who of automotive decision-making, including major carmakers, system suppliers, 1st tier and major 2nd tier award winning supplier companies.
VANCOUVER, BC , April 13, 2021 – ImagineAR (CSE: IP) (OTCQB: IPNFF) an Augmented Reality Company that enables sports teams, brands and businesses to instantly create mobile phone AR immersive engagement campaigns, is pleased to announce a three year revenue white label mobile app partnership agreement with Automotive Industries (AI) trade publication. Automotive Industries print audience plus Ai’s online readership are the who’s who of automotive decision-making, including major carmakers, system suppliers, 1st tier and major 2nd tier award winning supplier companies.
Automotive Industries (Ai) Publisher, John Larkin said “The automotive industry is often considered to be one of the most global of all industries, by 2022 there are expected to be 1 billion+ cars on the planet. The car makers are looking for the next innovation to benefit their consumers, their communication & their marketing partnerships. We believe computer vision AR and Alen Paul Silverrstieen’s team at ImagineAR are bringing the automotive industry and the world consumers of automobiles one of the best media communication assets since the introduction of the mobile phone.”
Alen Paul Silverrstieen, CEO & President of ImagineAR, stated “This is our first publishing partnership and solely focused on the business-to-business marketplace. John understands the revenue impact AR can deliver to his industry publication by increasing engagement and activations around the world leveraging our white-label mobile app platform with integrated content subscription channels. We are excited to transform the publishing business with Automotive Industries.”
“Hype Sports Innovation has been an amazing opportunity for ImagineAR to demonstrate our comprehensive Augmented Reality Platform to leading sports clubs, broadcasters, and publishers around the world. After being selected by 17 different organizations, we are excited to announce the first executed contract from the HYPE Virtual Accelerator 2021”, continued Mr. Silverrstieen.
About Automotive Industries Automotive Industries (Ai) is the world’s oldest continually published trade publication covering the automaking business. It was founded in November 1895 as “The Horseless Age,” the first magazine created to cover the world’s transition from horse-drawn conveyances to those powered by the new internal combustion engine. The magazine changed its name to “The Automobile” in July 1909 , an era when gasoline, steam and electricity all vied for preeminence in motive power.
The magazine’s present name was established in November 1917 . The title was briefly amended to “Automotive and Aviation Industries” during the World War II years, as the magazine expanded its coverage of technologies and production methods to include the aircraft industry, in which many automakers participated.
Automotive Industries is devoted to providing a global coverage on all aspects of the automobile marketplace, with an emphasis on the people, products and processes that shape the industry. Automotive Industries provides manufacturers and suppliers with in-depth news, information, insight and analysis on the global events that affect the auto industry. Visit Ai at www.i.ai
